Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Logo MUG-Forschungsportal

Krippl Peter |

** = Publikationen gelistet in SCI/SSCI/Pubmed

2022

Originalarbeit (Zeitschrift)

** Rinnerthaler, G; Singer, C; Petru, E; Egle, D; Petzer, A; Pluschnig, U; Gampenrieder, SP; Pfeiler, G; Gnant, M; Grünberger, B; Krippl, P; Strasser-Weippl, K; Suppan, C; Brunner, C; Pusch, R; Sandholzer, M; Balic, M; Bartsch, R Austrian treatment algorithms in HER2-positive metastatic breast cancer: a 2022 update.
Wien Klin Wochenschr. 2022; 134(19-20):683-692 Doi: 10.1007/s00508-022-02082-3 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

2021

Originalarbeit (Zeitschrift)

** Buxhofer-Ausch, V; Heibl, S; Sliwa, T; Beham-Schmid, C; Wolf, D; Geissler, K; Krauth, MT; Krippl, P; Petzer, A; Wölfler, A; Melchardt, T; Gisslinger, H Austrian recommendations for the management of essential thrombocythemia.
Wien Klin Wochenschr. 2021; 133(1-2):52-61 Doi: 10.1007/s00508-020-01761-3
Web of Science PubMed FullText FullText_MUG

 

2020

Fallbericht

** Bauer, PK; Krippl, P; Fabian, E; Mayer-Pickel, KI; Krause, R; Bauer, F; Krejs, GJ Clinical-Pathological Conference Series from the Medical University of Graz : Case No 174: A 25-year-old pregnant woman from Afghanistan with headache and a blast flag in the automated differential blood count.
Wien Klin Wochenschr. 2020; 132(13-14):403-409 Doi: 10.1007/s00508-020-01681-2 (- Case Report) [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

2019

Originalarbeit (Zeitschrift)

** Balic, M; Hilbe, W; Gusel, S; Fiegl, M; Ludwig, H; Mayrbaurl, B; Thaler, J; Samonigg, H; Hegenbarth, K; Eisner, F; Mlineritsch, B; Greil, R; Schandl, MJ; Weltermann, A; Petzer, A; Fuchs, D; Stangl, W; Krippl, P; Stauder, R; Stoger, H Prevalence of comorbidity in cancer patients scheduled for systemic anticancer treatment in Austria A cross-sectional multicentre observational study
MEMO-MAG EUR MED ONC. 2019; Doi: 10.1007/s12254-019-00542-7 [OPEN ACCESS]
Web of Science FullText FullText_MUG

 

2018

Originalarbeit (Zeitschrift)

** Krauth, MT; Burgstaller, S; Buxhofer-Ausch, V; Gastl, G; Geissler, K; Keil, F; Krippl, P; Melchardt, T; Petzer, A; Rumpold, H; Sliwa, T; Wöhrer, S; Wölfler, A; Gisslinger, H Ruxolitinib therapy for myelofibrosis in Austria : Consensus on therapy management.
WIEN KLIN WOCHENSCHR. 2018; 130(17-18): 495-504. Doi: 10.1007/s00508-018-1365-5 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Übersichtsarbeit

** Burgstaller, S; Buxhofer-Ausch, V; Sliwa, T; Beham-Schmid, C; Gastl, G; Geissler, K; Melchardt, T; Krauth, M; Krippl, P; Petzer, A; Rumpold, H; Wölfler, A; Gisslinger, H Austrian recommendations for the management of polycythemia vera.
Wien Klin Wochenschr. 2018; 130(17-18):535-542 Doi: 10.1007/s00508-018-1359-3 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2017

Originalarbeit (Zeitschrift)

** Sliwa, T; Beham-Schmid, C; Burgstaller, S; Buxhofer-Ausch, V; Gastl, G; Geissler, K; Krauth, M; Krippl, P; Lang, A; Petzer, A; Wöhrer, S; Wölfler, A; Gisslinger, H Austrian recommendations for the management of primary myelofibrosis, post-polycythemia vera myelofibrosis and post-essential thrombocythemia myelofibrosis: an expert statement.
Wien Klin Wochenschr. 2017; 129(9-10):293-302 Doi: 10.1007/s00508-016-1120-8 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2016

Abstract (Zeitschrift)

** Scheithauer, W; Prager, G; Greil, R; Mlineritsch, B; Schaberl-Moser, R; Gerger, A; Langle, F; Viragos-Toth, I; Andel, J; Pichler, A; Pecherstorfer, M; Kretschmer, A; Seebacher, A; Jagdt, B; Eisterer, W; Krippl, P Secondary resectability rates observed in a multicenter randomized phase II study of modified capecitabine/ irinotecan (mXELIRI) plus bevacizumab (bev) followed by capecitabine/oxaliplatin (XELOX) plus bev or the reverse sequence in patients with metastatic colorectal cancer (mCRC)
ANN ONCOL. 2016; 27: -41st Congress of the European-Society-for-Medical-Oncology (ESMO); OCT 07-11, 2016; Copenhagen, DENMARK. Doi: 10.1093/annonc/mdw370.41 [Poster]
Web of Science FullText FullText_MUG

 

** Zweiker, D; Rosch, K; Schumacher, M; Stepan, V; Krippl, P; Bauer, N; Heine, M; Reicht, G; Zweiker, G; Watzinger, N Benefit and Risk Assessment for the Initiation of oral Anticoagulation in non-valvular Atrial Fibrillation: The Self-assessment by the Patient differs from the individual Risk Assessment by means of CHA2DS2-VASc and HASBLED Scores
WIEN KLIN WOCHENSCHR. 2016; 128: S391-S392. [Poster]
Web of Science

 

** Zweiker, D; Rosch, K; Schumacher, M; Stepan, V; Krippl, P; Heine, M; Reicht, G; Zweiker, G; Watzinger, N Benefit and Risk Assessment in Initiation of oral Anticoagulant in non valvularem Atrial Fibrillation: A Comparison between Self Assessment by the Patient and an individual Risk Assessment by CHA2DS2VASc and HAS-BLED Scores
WIEN KLIN WOCHENSCHR. 2016; 128: S299-S300. [Poster]
Web of Science

 

2015

Originalarbeit (Zeitschrift)

** Langsenlehner, U; Hofmann, G; Renner, W; Gerger, A; Krenn-Pilko, S; Thurner, EM; Krippl, P; Langsenlehner, T Association of vascular endothelial growth factor - A gene polymorphisms and haplotypes with breast cancer metastases.
Acta Oncol. 2015; 54(3): 368-376. Doi: 10.3109/0284186X.2014.948056 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Abstract (Zeitschrift)

** Schmidt, S; Wolfler, A; Greil, R; Burgstaller, S; Sliwa, T; Petzer, A; Lang, A; Weltermann, A; Voskova, D; Mitterer, M; Valent, P; Eberhard, N; Walder, A; Geissler, K; Andel, J; Hausler, C; Ludescher, C; Oexle, H; Korger, M; Schnallinger, M; Schreieck, S; Krippl, P; Wiesholzer, M; Woll, E; Geissler, D; Rochau, U; Siebert, U; Thaler, J; Gastl, G Tyrosin kinase inhibitors usage and response analysis in the Austrian CML registry cohort
ONCOL RES TREAT. 2015; 38: 133-133. [Poster]
Web of Science

 

2014

Abstract (Zeitschrift)

** Pleyer, L; Burgstaller, S; Stauder, R; Girschikofsky, M; Linkesch, W; Pfeilstocker, M; Autzinger, EM; Tinchon, C; Sliwa, T; Lang, A; Sperr, WR; Geissler, D; Krippl, P; Voskova, D; Rossmann, DH; Schlick, K; Thaler, J; Halter, B; Machherndl-Spandl, S; Theiler, G; Valent, P; Eckmullner, O; Greil, R Azacitidine in Patients with Acute Myeloid Leukemia: Assessing the Potential Negative Impact of Elevated Baseline White Blood Cell Count on Outcome
BLOOD. 2014; 124(21): Doi: 10.1182/blood.V124.21.2284.2284
Web of Science FullText FullText_MUG

 

** Pleyer, L; Burgstaller, S; Stauder, R; Girschikofsky, M; Linkesch, W; Pfeilstocker, M; Autzinger, EM; Tinchon, C; Sliwa, T; Lang, A; Sperr, WR; Geissler, D; Krippl, P; Voskova, D; Rossmann, DH; Schlick, K; Thaler, J; Halter, B; Machherndl-Spandl, S; Theiler, G; Valent, P; Eckmullner, O; Greil, R Azacitidine in Acute Myeloid Leukemia: Comparison of Patients with AML-MRF Vs AML-NOS Enrolled in the Austrian Azacitidine Registry
BLOOD. 2014; 124(21):
Web of Science

 

** Pleyer, L; Burgstaller, S; Stauder, R; Girschikofsky, M; Linkesch, W; Pfeilstocker, M; Autzinger, EM; Tinchon, C; Sliwa, T; Lang, A; Sperr, WR; Geissler, D; Krippl, P; Voskova, D; Rossmann, DH; Schlick, K; Thaler, J; Halter, B; Machherndl-Spandl, S; Theiler, G; Valent, P; Eckmullner, O; Greil, R Azacitidine in Patients with Relapsed/Refractory Acute Myeloid Leukemia : Retrospective Analysis of the Austrian Azacitidine Registry
BLOOD. 2014; 124(21):
Web of Science

 

** Pleyer, L; Burgstaller, S; Stauder, R; Girschikofsky, M; Linkesch, W; Pfeilstocker, M; Autzinger, EM; Tinchon, C; Sliwa, T; Lang, A; Sperr, WR; Geissler, D; Krippl, P; Voskova, D; Rossmann, DH; Schlick, K; Thaler, J; Halter, B; Machherndl-Spandl, S; Theiler, G; Valent, P; Eckmullner, O; Greil, R Azacitidine in Patients with Acute Myeloid Leukemia: Impact of Intermediate-Risk Vs High-Risk Cytogenetics on Patient Outcomes
BLOOD. 2014; 124(21):
Web of Science

 

** Pleyer, L; Burgstaller, S; Stauder, R; Girschikofsky, M; Linkesch, W; Pfeilstoker, M; Autzinger, EM; Tinchon, C; Sliwa, T; Lang, A; Sperr, WR; Geissler, D; Krippl, P; Voskova, D; Rossmann, DH; Schlick, K; Thaler, J; Halter, B; Machherndl-Spandl, S; Theiler, G; Valent, P; Eckmullner, O; Greil, R Azacitidine in Patients with Treatment-Related Acute Myeloid Leukemia: Retrospective Analysis of the Austrian Azacitidine Registry
BLOOD. 2014; 124(21): Doi: 10.1182/blood.V124.21.3681.3681
Web of Science FullText FullText_MUG

 

2012

Abstract (Zeitschrift)

** Hofmann, G; Langsenlehner, T; Moazedi-Fuerst, F; Gerger, A; Kielhauser, S; Absenger, G; Szkandera, J; Samonigg, H; Krippl, P; Renner, W; COMMON VEGF GENE POLYMORPHISMS ARE NOT ASSOCIATED WITH RELAPSE-FREE SURVIVAL IN COLORECTAL CANCER PATIENTS.
ANN ONCOL. 2012; 23: 86-87.-14th World Congress on Gastrointestinal Cancer of the European-Society-for-Medical-Oncology (ESMO); JUN 27-30, 2012; Barcelona, SPAIN. [Poster]
Web of Science

 

** Hofmann, G; Langsenlehner, T; Moazedi-Fuerst, F; Gerger, A; Kielhauser, S; Thurner, E-M; Absenger, G; Szkandera, J; Samonigg, H; Glehr, M; Krippl, P; Renner, W Genetic variants of UGT1A4 and their impact on relapse-free survival in Tamoxifen treated breast cancer patients.
Onkologie. 2012; 35(S 6):64-64.-Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Onkologie; OCT 19-23, 2012; Stuttgart, GERMANY. [Poster]
Web of Science

 

** Rossmann, C; Balic, M; Krippl, P; COMPARISON OF OVERALL SURVIVAL IN METASTATIC COLORECTAL CANCER PATIENTS - DAILY PRACTICE VERSUS RANDOMIZED TRIALS.
ANN ONCOL. 2012; 23: 95-95.-14th World Congress on Gastrointestinal Cancer of the European-Society-for-Medical-Oncology (ESMO); JUN 27-30, 2012; Barcelona, SPAIN. [Poster]
Web of Science

 

2011

Originalarbeit (Zeitschrift)

** Hofmann, G; Langsenlehner, U; Langsenlehner, T; Glehr, M; Gerger, A; Absenger, G; Szkandera, J; Fuerst, F; Samonigg, H; Krippl, P; Renner, W Single nucleotide polymorphisms of integrin alpha-2 and beta-3 genes are not associated with relapse-free and overall survival in colorectal cancer patients.
Anticancer Res. 2011; 31(4):1373-1377
Web of Science PubMed

 

** Parmar, S; Stingl, JC; Huber-Wechselberger, A; Kainz, A; Renner, W; Langsenlehner, U; Krippl, P; Brockmöller, J; Haschke-Becher, E Impact of UGT2B7 His268Tyr polymorphism on the outcome of adjuvant epirubicin treatment in breast cancer.
Breast Cancer Res. 2011; 13(3):R57-R57 Doi: 10.1186/bcr2894 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Abstract (Zeitschrift)

** Hofmann, G; Langsenlehner, T; Fuerst, F; Gerger, A; Langsenlehner, U; Bitsche, S; Absenger, G; Samonigg, H; Krippl, P; Renner, W RELAPSE-FREE SURVIVAL IN COLORECTAL CANCER PATIENTS IS NOT ASSOCIATED WITH SINGLE NUCLEOTIDE POLYMORPHISMS IN INTEGRIN RECEPTOR SUBUNITS
ANN ONCOL. 2011; 22: v109-v109.-ESMO 13th World Congress on Gastrointestinal Cancer ; JUN 22-25, 2011; Barcelona, SPAIN. [Poster]
Web of Science

 

** Hofmann, G; Langsenlehner, T; Fuerst, F; Gerger, A; Langsenlehner, U; Szkandera, J; Absenger, G; Samonigg, H; Krippl, P; Renner, W A COMMON HEREDITARY SINGLE NUCLEOTIDE POLYMORPHISM IN THE IN THE GENE OF DEATH RECEPTOR 4 (TNFRSF10A) AND ITS IMPACT ON OVERALL SURVIVAL IN RECTAL CANCER PATIENTS
ANN ONCOL. . 2011; 22: v129-v129.-ESMO 13th World Congress on Gastrointestinal Cancer; JUN 22-25, 2011; Barcelona, SPAIN. [Poster]
Web of Science

 

** Hofmann, G; Langsenlehner, T; Fuerst, F; Gerger, A; Langsenlehner, U; Szkandera, J; Absenger, G; Samonigg, H; Krippl, P; Renner, W Common single nucleotide polymorphisms in the genes of integrin alpha-2 and beta-3 subunits are not associated with overall survival in rectal cancer patients
ONKOLOGIE. 2011; 34: 245-246.-Gemeinsame Jahrestagung 2011 der DGHO, ÖGHO, SGMO und SGH+SSH; SEP 30-OCT 4, 2011; Basel, SWITZERLAND. [Poster]
Web of Science

 

2010

Originalarbeit (Zeitschrift)

** Gerger, A; Renner, W; Langsenlehner, T; Hofmann, G; Knechtel, G; Szkandera, J; Samonigg, H; Krippl, P; Langsenlehner, U Association of interleukin-10 gene variation with breast cancer prognosis.
Breast Cancer Res Treat. 2010; 119(3):701-705 Doi: 10.1007/s10549-009-0417-y
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Knechtel, G; Szkandera, J; Stotz, M; Hofmann, G; Langsenlehner, U; Krippl, P; Samonigg, H; Renner, W; Langner, C; Dehchamani, D; Gerger, A Single nucleotide polymorphisms in the hypoxia-inducible factor-1 gene and colorectal cancer risk.
Mol Carcinog. 2010; 49(9):805-809 Doi: 10.1002/mc.20655
Web of Science PubMed FullText FullText_MUG

 

** Yazdani-Biuki, B; Krippl, P; Brickmann, K; Fuerst, F; Langsenlehner, U; Paulweber, B; Pilger, E; Wascher, TC; Brezinschek, HP; Renner, W The functional promoter polymorphism of the coagulation factor XII gene is not associated with peripheral arterial disease.
Angiology. 2010; 61(2):211-215 Doi: 10.1177/0003319709337305
Web of Science PubMed FullText FullText_MUG

 

2009

Originalarbeit (Zeitschrift)

** Hofmann, G; Langsenlehner, U; Langsenlehner, T; Yazdani-Biuki, B; Clar, H; Gerger, A; Fuerst, F; Samonigg, H; Krippl, P; Renner, W A common hereditary single-nucleotide polymorphism in the gene of FAS and colorectal cancer survival.
J Cell Mol Med. 2009; 13(9B):3699-3702 Doi: 10.1111/j.1582-4934.2009.00720.x [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

2008

Abstract (Zeitschrift)

** Hofmann, G; Langsenlehner, T; Fuerst, F; Gerger, A; Langsenlehner, U; Samonigg, H; Clar, H; Krippl, P; Renner, W Association of a common-670 A > G polymorphism in the gene of TNFRSF6 (FAS) with overall survival in colorectal cancer patients
ANN ONCOL. 2008; 19(S 6):68-68. [Oral Communication]
Web of Science

 

2007

Originalarbeit (Zeitschrift)

** Eder, T; Mayer, R; Langsenlehner, U; Renner, W; Krippl, P; Wascher, TC; Pummer, K; Kapp, KS Interleukin-10 [ATA] promoter haplotype and prostate cancer risk: a population-based study.
Eur J Cancer. 2007; 43(3):472-475 Doi: 10.1016/j.ejca.2006.11.003
Web of Science PubMed FullText FullText_MUG

 

** Gerger, A; Langsenlehner, U; Renner, W; Weitzer, W; Eder, T; Yazdani-Biuki, B; Hofmann, G; Samonigg, H; Krippl, P A multigenic approach to predict breast cancer risk.
Breast Cancer Res Treat. 2007; 104(2):159-164 Doi: 10.1007/s10549-006-9408-4
Web of Science PubMed FullText FullText_MUG

 

Abstract (Zeitschrift)

** Hofmann, G; Gerger, A; Weitzer, W; Langsenlehner, T; Fuerst, F; Renner, W; Samonigg, H; Krippl, P; Langsenlehner, U The ITGA2 807C > T polymorphism is associated with reduced colorectal cancer susceptibility
ANN ONCOL. 2007; 18: VII38-VII38.-2007 World Congress on Gastrointestinal Cancer; JUN 27-30, 2007; Barcelona, SPAIN. [Poster]
Web of Science

 

Kommentar

** Langsenlehner, U; Gerger, A; Weitzer, W; Krippl, P COX-2 expression in canine and feline invasive mammary carcinomas: correlation with clinicopathological features and prognostic for molecular markers.
Breast Cancer Res Treat. 2007; 101(2): 247-247. Doi: 10.1007/s10549-006-9291-z
Web of Science PubMed FullText FullText_MUG

 

2006

Originalarbeit (Zeitschrift)

** Gerger, A; Koller, S; Weger, W; Richtig, E; Kerl, H; Samonigg, H; Krippl, P; Smolle, J Sensitivity and specificity of confocal laser-scanning microscopy for in vivo diagnosis of malignant skin tumors.
Cancer. 2006; 107(1): 193-200. Doi: 10.1002/cncr.21910 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG Pressetext

 

** Hofmann, G; Bauernhofer, T; Krippl, P; Lang-Loidolt, D; Horn, S; Goessler, W; Schippinger, W; Ploner, F; Stoeger, H; Samonigg, H Plasmapheresis reverses all side-effects of a cisplatin overdose--a case report and treatment recommendation.
BMC Cancer. 2006; 6(2):1-1 Doi: 10.1186/1471-2407-6-1 (- Case Report) [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG Google Scholar

 

** Langsenlehner, U; Yazdani-Biuki, B; Eder, T; Renner, W; Wascher, TC; Paulweber, B; Weitzer, W; Samonigg, H; Krippl, P The cyclooxygenase-2 (PTGS2) 8473T>C polymorphism is associated with breast cancer risk.
Clin Cancer Res. 2006; 12(4):1392-1394 Doi: 10.1158/1078-0432.CCR-05-2055 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Leithner, K; Leithner, A; Clar, H; Weinhaeusel, A; Radl, R; Krippl, P; Rehak, P; Windhager, R; Haas, OA; Olschewski, H Mesothelioma mortality in Europe: impact of asbestos consumption and simian virus 40.
Orphanet J Rare Dis. 2006; 1(3): 44-44. Doi: 10.1186/1750-1172-1-44 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG Google Scholar

 

** Yazdani-Biuki, B; Brickmann, K; Wohlfahrt, K; Mueller, T; März, W; Renner, W; Gutjahr, M; Langsenlehner, U; Krippl, P; Wascher, TC; Paulweber, B; Graninger, W; Brezinschek, HP The MHC2TA -168A>G gene polymorphism is not associated with rheumatoid arthritis in Austrian patients.
Arthritis Res Ther. 2006; 8(4):R97-R97 Doi: 10.1186/ar1974 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Abstract (Zeitschrift)

** Gerger, A; Horn, M; Samonigg, H; Langsenlehner, U; Krippl, P; Kerl, H; Smolle, J Diagnostic virtual histopathology of untreated fresh specimens from squamous cell carcinoma using confocal laser-scanning microscopy
J INVEST DERMATOL. 126: 114-114.-European Society of Dermatological Research; Sep, 2006; Paris, France. [Oral Communication]
Web of Science

 

** Gerger, A; Kerl, H; Samonigg, H; Langsenlehner, U; Krippl, P; Smolle, J Sensitivity and specificity of confocal laser scanning microscopy for in vivo diagnosis of malignant skin tumors
J INVEST DERMATOL. 126: 114-114.-European Society of Dermatological Research; Sep, 2006; Paris, France. [Poster]
Web of Science

 

** Langsenlehner, U; Eder, T; Renner, W; Gerger, A; Hofmann, G; Samonigg, H; Krippl, P The cyclooxygenase-2 (PTGS2) 8473T > C polymorphism increases breast cancer risk.
BREAST CANCER RES TREAT. 2006; 100: S251-S252.-29th Annual San Antonio Breast Cancer Symposium; DEC 14-17, 2006; San Antonio, USA. [Poster]
Web of Science

 

2005

Originalarbeit (Zeitschrift)

** Bahadori, B; Yazdani-Biuki, B; Krippl, P; Brath, H; Uitz, E; Wascher, TC Low-fat, high-carbohydrate (low-glycaemic index) diet induces weight loss and preserves lean body mass in obese healthy subjects: results of a 24-week study.
Diabetes Obes Metab. 2005; 7(3):290-293 Doi: 10.1111/j.1463-1326.2004.00445.x
Web of Science PubMed FullText FullText_MUG

 

** Langsenlehner, U; Krippl, P; Renner, W; Yazdani-Biuki, B; Eder, T; Köppel, H; Wascher, TC; Paulweber, B; Samonigg, H Interleukin-10 promoter polymorphism is associated with decreased breast cancer risk.
Breast Cancer Res Treat. 2005; 90(2):113-115 Doi: 10.1007/s10549-004-3607-7
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Leithner, A; Gapp, M; Radl, R; Pascher, A; Krippl, P; Leithner, K; Windhager, R; Beham, A Immunohistochemical analysis of desmoid tumours.
J CLIN PATHOL. 2005; 58(11): 1152-1156. Doi: 10.1136/jcp.2005.026278 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Kurzbericht/Letter

** Langsenlehner, U; Hofmann, G; Samonigg, H; Krippl, P; Renner, W; Clar, H Cyclin D1 genotype and breast cancer metastasis.
CANCER EPIDEM BIOMARKER PREV. 2005; 14: 1844-1845. Doi: 10.1158/1055-9965.EPI-05-0204 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Abstract (Zeitschrift)

** Hofmann, G; Langsenlehner, U; Renner, W; Greimel, A; Samonigg, H; Krippl, P Breast cancer metastasis-free survival and its association to a common hereditary gene polymorphism of cyclin D1
BREAST CANCER RES TREAT. 94: S-78-S-79.
Web of Science

 

** Langsenlehner, U; Eder, T; Weitzer, W; Samonigg, H; Krippl, P The most common integrin ITGA2 haplotype (807C_1648G, wildtype) is associated with decreased breast cancer risk
BREAST CANCER RES TREAT 2005 94: -.
Web of Science

 

** Langsenlehner, U; Krippl, P; Eder, T; Weitzer, W; Samonigg, H Interleukin-10 TCATA haplotype is associated with decreased breast cancer risk
ANN ONCOL 2005 16: 271-271.
Web of Science

 

2004

Originalarbeit (Zeitschrift)

** Köppel, H; Renner, W; Krippl, P; Wascher, TC; Pilger, E Diminished response to activated protein C is not correlated with severity of peripheral arterial occlusive disease.
Clin Lab. 2004; 50(11-12): 689-693.
PubMed Google Scholar

 

** Krippl, P; Langsenlehner, U; Renner, W; Yazdani-Biuki, B; Köppel, H; Leithner, A; Wascher, TC; Paulweber, B; Samonigg, H The 5A/6A polymorphism of the matrix metalloproteinase 3 gene promoter and breast cancer.
Clin Cancer Res. 2004; 10(10):3518-3520 Doi: 10.1158/1078-0432.CCR-04-0010 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Krippl, P; Langsenlehner, U; Renner, W; Yazdani-Biuki, B; Wolf, G; Wascher, TC; Paulweber, B; Samonigg, H The 825C>T polymorphism of the G-protein beta-3 subunit gene (GNB3) and breast cancer.
CANCER LETT. 2004; 206(1): 59-62. Doi: 10.1016/j.canlet.2003.11.030
Web of Science PubMed FullText FullText_MUG

 

** Langsenlehner, U; Krippl, P; Renner, W; Yazdani-Biuki, B; Eder, T; Wolf, G; Wascher, TC; Paulweber, B; Weitzer, W; Samonigg, H Genetic variants of the sulfotransferase 1A1 and breast cancer risk.
Breast Cancer Res Treat. 2004; 87(1):19-22 Doi: 10.1023/B:BREA.0000041574.90735.ea
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Leithner, A; Gapp, M; Leithner, K; Radl, R; Krippl, P; Beham, A; Windhager, R Margins in extra-abdominal desmoid tumors: a comparative analysis.
J Surg Oncol. 2004; 86(3):152-156 Doi: 10.1002/jso.20057
Web of Science PubMed FullText FullText_MUG

 

** Schippinger, W; Regitnig, P; Bauernhofer, T; Ploner, F; Hofmann, G; Krippl, P; Wehrschütz, M; Lax, S; Carney, W; Neumann, R; Wernecke, KD; Samonigg, H The course of serum HER-2/neu levels as an independent prognostic factor for survival in metastatic breast cancer.
ONCOL REP. 2004; 11(6): 1331-1336. Doi: 10.3892/or.11.6.1331
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Wolf, G; Aigner, RM; Schaffler, G; Langsenlehner, U; Renner, W; Samonigg, H; Yazdani-Biuki, B; Krippl, P The 936C>T polymorphism of the gene for vascular endothelial growth factor is associated with 18F-fluorodeoxyglucose uptake.
BREAST CANCER RES TREAT. 2004; 88(3): 205-208. Doi: 10.1007/s10549-004-0724-2
Web of Science PubMed FullText FullText_MUG

 

Kurzbericht/Letter

** Köppel, H; Krippl, P; Gasser, R; Wascher, TC; Paulweber, B; Pilger, E; Renner, W Hemochromatosis gene (HFE) polymorphisms are not associated with peripheral arterial disease.
Thromb Haemost. 2004; 91(6):1258-1259 Doi: 10.1267/THRO04061258
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Krippl, P; Langsenlehner, U; Samonigg, H; Renner, W; Köppel, H Vascular endothelial growth factor in predicting outcome in breast cancer.
CLIN CANCER RES 2004 10: 8752-8753. Doi: 10.1158/1078-0432.CCR-04-1211 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Yazdani-Biuki, B; Stelzl, H; Brezinschek, HP; Hermann, J; Mueller, T; Krippl, P; Graninger, W; Wascher, TC Improvement of insulin sensitivity in insulin resistant subjects during prolonged treatment with the anti-TNF-alpha antibody infliximab.
EUR J CLIN INVEST. 2004; 34(9): 641-642. Doi: 10.1111/j.1365-2362.2004.01390.x (- Case Report)
Web of Science PubMed FullText FullText_MUG Google Scholar

 

Korrespondenz

** Krippl, P; Langsenlehner, U; Renner, W; Köppel, H; Samonigg, H Re: Polymorphisms of death pathway genes FAS and FASL in esophageal squamous-cell carcinoma.
J NAT CANCER INST. 2004; 96: 1478-1479. Doi: 10.1093/jnci/djh289 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Abstract (Zeitschrift)

** Krippl, P; Langsenlehner, U; Eder, T; Samonigg, H The 5A/6A polymorphism of the stromelysin I gene promotor and breast cancer
BRIT J CANCER 2004 91: S25-S25.
Web of Science

 

** Krippl, P; Langsenlehner, U; Samonigg, H The 825C > T polymorphism of the G-protein beta-3 subunit gene (GNB3) and breast cancer
BRIT J CANCER 2004 91: S56-S56.
Web of Science

 

** Langsenlehner, U; Krippl, P; Eder, T; Samonigg, H The SULT1A1 213H variant is associated with the presence of lymph node metastases in breast cancer patients
BRIT J CANCER 2004 91: S26-S26.
Web of Science

 

** Langsenlehner, U; Krippl, P; Samonigg, H The 677C > T polymorphism of methylenetetrahydro folate reductase gene and susceptibility to breast cancer
BRIT J CANCER 2004 91: S26-S26.
Web of Science

 

** Langsenlehner, U; Samonigg, H; Krippl, P The-1377G > A polymorphism in the FAS promoter region is associated with increased breast cancer susceptibility.
BREAST CANCER RES TREAT 2004 88: S72-S72.
Web of Science

 

** Langsenlehner, U; Samonigg, H; Krippl, P Vascular endothelial growth factor gene polymorphism decreases the risk for breast cancer metastasis.
BREAST CANCER RES TREAT 2004 88: S144-S145.
Web of Science

 

2003

Originalarbeit (Zeitschrift)

** Denison, U; Baumann, J; Peters-Engl, C; Samonigg, H; Krippl, P; Lang, A; Obermair, A; Wagner, H; Sevelda, P Incidence of anaemia in breast cancer patients receiving adjuvant chemotherapy.
Breast Cancer Res Treat. 2003; 79(3):347-353 Doi: 10.1023/A:1024016508925
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Krippl, P; Langsenlehner, U; Renner, W; Yazdani-Biuki, B; Wolf, G; Wascher, TC; Paulweber, B; Bahadori, B; Samonigg, H The L10P polymorphism of the transforming growth factor-beta 1 gene is not associated with breast cancer risk.
Cancer Lett. 2003; 201(2):181-184 Doi: 10.1016/S0304-3835(03)00468-3
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Krippl, P; Langsenlehner, U; Renner, W; Yazdani-Biuki, B; Wolf, G; Wascher, TC; Paulweber, B; Haas, J; Samonigg, H A common 936 C/T gene polymorphism of vascular endothelial growth factor is associated with decreased breast cancer risk.
Int J Cancer. 2003; 106(4):468-471 Doi: 10.1002/ijc.11238 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Krippl, P; Langsenlehner, U; Renner, W; Yazdani-Biuki, B; Wolf, G; Wascher, TC; Paulweber, B; Weitzer, W; Leithner, A; Samonigg, H The 870G>A polymorphism of the cyclin D1 gene is not associated with breast cancer.
Breast Cancer Res Treat. 2003; 82(3):165-168 Doi: 10.1023/B:BREA.0000004372.20461.33
Web of Science PubMed FullText FullText_MUG

 

** Langsenlehner, U; Krippl, P; Renner, W; Yazdani-Biuki, B; Wolf, G; Wascher, TC; Paulweber, B; Weitzer, W; Samonigg, H The common 677C>T gene polymorphism of methylenetetrahydrofolate reductase gene is not associated with breast cancer risk.
Breast Cancer Res Treat. 2003; 81(2):169-172 Doi: 10.1023/A:1025752420309
Web of Science PubMed FullText FullText_MUG

 

** Wolf, G; Aigner, RM; Schaffler, G; Schwarz, T; Krippl, P Pathology results in [18F]fluorodeoxyglucose positron emission tomography of the thyroid gland.
Nucl Med Commun. 2003; 24(12):1225-1230 Doi: 10.1097/01.mnm.0000104643.79626.a1
Web of Science PubMed FullText FullText_MUG

 

** Wolf, G; Aigner, RM; Schwarz, T; Krippl, P; Samonigg, H Diagnosis of a contralateral second testicular carcinoma by F18-FDG PET.
Onkologie. 2003; 26(2):155-157 Doi: 10.1159/000069836 (- Case Report)
Web of Science PubMed FullText FullText_MUG Google Scholar

 

Abstract (Zeitschrift)

** Krippl, P; Langsenlehner, U; Renner, W; Samonigg, H A common 936 C/T gene polymorphism of vascular endothelial growth factor is associated with decreased breast cancer risk.
BREAST CANCER RES TREAT 2003 82: S140-S140.
Web of Science

 

** Schippinger, W; Bauernhofer, T; Regitnig, P; Ploner, F; Krippl, P; Hofmann, G; Lax, S; Carney, W; Neumann, R; Wernecke, KD; Samonigg, H Serum HER-2/neu dynamics in metastatic breast cancer as an independent prognostic factor.
BREAST CANCER RES TREAT 2003 82: S123-S123.
Web of Science

 

2002

Originalarbeit (Zeitschrift)

** Wehrschütz, M; Stöger, H; Ploner, F; Hofmann, G; Wolf, G; Höfler, G; Krippl, P; Samonigg, H Seminoma metastases mimicking primary pancreatic cancer.
Onkologie. 2002; 25(4):371-373 Doi: 10.1159/000066057 (- Case Report)
Web of Science PubMed FullText FullText_MUG

 

** Wolf, G; Aigner, RM; Humer-Fuchs, U; Schwarz, T; Krippl, P; Wehrschuetz, M Renal cell carcinoma metastasis in a microfollicular adenoma of the thyroid gland.
Acta Med Austriaca. 2002; 29(4):141-142 Doi: 10.1046/j.1563-2571.2002.02009.x (- Case Report)
Web of Science PubMed FullText FullText_MUG

 

Abstract (Zeitschrift)

** Schippinger, W; Bauernhofer, T; Ploner, F; Hofmann, G; Krippl, P; Neumann, R; Wernecke, KD; Samonigg, H Serum HER-2/neu levels correlate with time to progression in therapy of metastatic breast cancer.
BREAST CANCER RES TREAT 2002 76: S104-S104.
Web of Science

 

↑ Seitenanfang / Navigation

© Med Uni Graz • Impressum